AMERIGON INC
10-Q, 1998-05-07
MOTOR VEHICLES & PASSENGER CAR BODIES
Previous: REXALL SUNDOWN INC, 424B4, 1998-05-07
Next: BERMAN LYLE, SC 13G, 1998-05-07



<PAGE>

                                          
                         SECURITIES AND EXCHANGE COMMISSION
                               WASHINGTON, D.C. 20549
                                          
                                     FORM 10-Q
                                          
                                     (Mark One)

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE

                  For the quarterly period ended March 31, 1998

[ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934

       For the transition period from __________________ to ________________.

                         Commission File Number: 0 - 21810
                                          
                               AMERIGON INCORPORATED
                               ---------------------
               (Exact name of registrant as specified in its charter)


               California                              95-4318554
- --------------------------------------  --------------------------------------
      (State or other jurisdiction of     (I.R.S. Employer Identification No.)
     incorporation or organization)


5462 Irwindale Avenue, Irwindale, California              91706
- --------------------------------------------    ------------------------------
(Address of principal executive offices)              (Zip Code)

          Registrant's telephone number, including area code: (626) 815-7400

Indicate by check mark whether the registrant (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 
1934 during the preceding 12 months (or for such shorter period that the 
registrant was required to file such reports), and (2) has been subject to 
such filing requirements for the past 90 days.    Yes  X  No
                                                      ---    ---

At April 15, 1998 the registrant had 12,550,445 shares of Class A Common 
Stock, no par value; no shares of Class B Common Stock, no par value; and no 
shares Preferred Stock, no par value, issued and outstanding.

<PAGE>
                                          
                               AMERIGON INCORPORATED
                                          
                                 TABLE OF CONTENTS
                                          


Part I.        FINANCIAL INFORMATION

     Item 1.   Financial Statements

               Balance Sheets                                        3

               Statements of Operations                              4
    
               Statements of Cash Flows                              5

               Notes to Financial Statements                         6

    Item 2.    Management's Discussion and Analysis of
               Financial Condition and Results of Operations         8

Part II OTHER INFORMATION                                           11

    Item 6. Exhibits and Reports on Form 8-K

    Signature                                                       12


                                     (2)
<PAGE>

PART I

                          ITEM 1. FINANCIAL STATEMENTS
                              AMERIGON INCORPORATED
                        (A DEVELOPMENT STAGE ENTERPRISE)

                                 BALANCE SHEETS
                                 (IN THOUSANDS)
<TABLE>
<CAPTION>
                                                        December 31,     March 31,
                                                            1997           1998 
                                                        ------------    -----------
                                ASSETS                                  (unaudited)
<S>                                                      <C>            <C>
Current Assets:
    Cash & cash equivalents                                $6,037         $4,822 
    Short term investments                                  2,400          1,393 
    Accounts receivable less allowance of $80                 255            114 
    Receivable due from joint venture partner               1,000          1,000 
    Inventory, primarily raw materials                         35            193 
    Prepaid expenses and other assets                         196            148 
                                                        ------------    -----------
          Total current assets                              9,923          7,670 

Property and equipment, net                                   645            911 
                                                        ------------    -----------
    Total Assets                                          $10,568         $8,581 
                                                        ------------    -----------
                                                        ------------    -----------

                 LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilites:
    Accounts payable                                         $650           $616 
    Deferred revenue                                           97             97 
    Accrued liabilities                                       350            261 
                                                        ------------    -----------
        Total current liabilities                           1,097            974 

Long term portion of capital lease                             41             34 
                                                        ------------    -----------

Shareholders' Equity:
    Preferred stock, no par value; 5,000 shares
         authorized, none issued and outstanding
    Common Stock;
      Class A - no par value; 40,000 shares authorized,
       9,550 issued and outstanding at
       March 31, 1998 and December 31, 1997
       (An additional 3,000 shares held in escrow)         28,149         28,149 
      Class B - no par value; 3,000 shares authorized,
       none issued and outstanding                                 -              -
    Contributed capital                                     9,882          9,882 
    Deficit accumulated during development stage          (28,601)       (30,458)
                                                        ------------    -----------
        Total shareholders' equity (deficit)                9,430          7,573 

                                                        ------------    -----------
        Total Liabilities and Shareholders' Equity        $10,568         $8,581 
                                                        ------------    -----------
                                                        ------------    -----------
</TABLE>

            See accompanying notes to the condensed financial statements


                                     (3)
<PAGE>

                            AMERIGON INCORPORATED 
                      (A DEVELOPMENT STAGE ENTERPRISES)
    
                          STATEMENTS OF OPERATIONS 
                    (IN THOUSANDS, EXCEPT PER SHARE DATA) 
                                 (UNAUDITED)

<TABLE>
<CAPTION>
                                                                            From
                                                                        April 23,1991
                                                      Three Months       (inception)
                                                      Ended March 31,    to March 31,
                                                    ------------------  -------------
                                                    1997          1998       1998
                                                    ----          ----       ----
<S>                                                <C>           <C>         <C>
Revenues:                                                
    Development contracts and 
     related grants                                $  384        $  84        $17,294 
    Grants                                             12            -          6,183 
                                                   ------        -----        -------
        Total Revenue                                 396           84         23,477 
                                                   ------        -----        -------
Costs And Expenses:                                      
  Direct development contract and 
    related grant costs                               869            -         20,904 
  Direct grant costs                                   28            -          4,757 
  Research and development                            256        1,024         11,883 
  Selling, general and administrative,
    including reimbursable expenses                   794        1,013         19,271 
                                                   ------        -----        -------
      Total Costs and Expenses                      1,947        2,037         56,815 
                                                   ------        -----        -------
Operating Loss                                     (1,551)      (1,953)       (33,338)

Interest income                                        67           96          1,139 
Interest expense                                     (117)           -           (282)
Gain on disposal of assets                              -            -          2,363 
                                                   ------        -----        -------
Net loss before extraordinary item                ($1,601)     ($1,857)      ($30,118)
Extraordinary loss from extinguishment                   
    of indebtedness                                  (340)           -           (340)
                                                   ------        -----        -------
Net loss                                          ($1,941)     ($1,857)      ($30,458)
                                                   ------        -----        -------
                                                   ------        -----        -------
Basic and diluted net loss per share                     
  before extraordinary item                        ($0.25)      ($0.19)
                                                   ------        -----    
                                                   ------        -----    
Basic and diluted net loss per share               ($0.30)      ($0.19)
                                                   ------        -----    
                                                   ------        -----    
Weighted average number of shares outstanding       6,488       9,550 
                                                   ------        -----    
                                                   ------        -----    
</TABLE>

            See accompanying notes to the condensed financial statements      

                                      (4)
                                          





<PAGE>

                            AMERIGON INCORPORATED 
                      (A DEVELOPMENT STAGE ENTERPRISES)
    
                           STATEMENTS OF CASH FLOWS
                               (IN THOUSANDS)
                                 (UNAUDITED)

<TABLE>
<CAPTION>
                                                                            From
                                                                        April 23,1991
                                                      Three Months       (inception)
                                                      Ended March 31,    to March 31,
                                                    1997          1998       1998
                                                  --------      -------  ------------
<S>                                                <C>           <C>         <C>
Operating Activities:
  Net loss                                        ($1,941)      ($1,857)    ($30,458)
  Adjustments to reconcile net loss to 
   cash used in operating activities:
    Depreciation and amortization                      97           104        1,178 
    Provision for doubtful account                      -             -          190 
    Stock option compensation                           -             -          712 
    Gain from sale of assets                            -             -       (2,363)
    Contributed capital-founders'
     services without cash compensation                 -             -          300 
    Change in operating assets and liabilities:
       Accounts receivable                           (621)          141         (304)
       Unbilled revenue                               915             -            -
       Inventory                                        -          (158)        (213)
       Prepaid expenses and other assets              529            48         (148)
       Accounts payable                            (1,058)          (34)         268 
       Deferred revenue                                85             -           97 
       Accrued liabilities                             99           (89)         297 
                                                  -------        ------       ------
    Net cash used in operating activities          (1,895)       (1,845)     (30,444)
                                                  -------        ------       ------

Investing Activities:
    Purchase of property and equipment                (30)         (370)      (2,116)
    Proceeds from sale of assets                        -             -        2,800 
    Receivable from sale of assets                      -             -       (1,000)
    Short term-investments sold (purchased)             -         1,007       (1,393)
                                                  -------        ------       ------
      Net cash used in investing activities           (30)          637       (1,709)
                                                  -------        ------       ------

Financing Activities:
    Proceeds sale of common stock units, net       17,704             -       34,772 
    Proceeds from exercise of stock options             -             -          160 
    Repurchase of common stock                          -             -          (15)
    Borrowing under line of credit                      -             -        6,280 
    Repayment of line of credit                    (1,187)            -       (6,280)
    Repayment of capital lease                         (4)           (7)         (44)
    Proceeds from Bridge Financing                      -             -        3,000 
    Repayment of Bridge Financing                  (2,850)            -       (3,000)
    Proceeds of notes payable to shareholder          250             -          450 
    Repayment of notes payable to shareholder        (450)            -         (450)
    Notes payable to shareholders contributed
     capital                                            -             -        2,102 
                                                  -------        ------       ------
      Net cash provided by financing activities    13,463            (7)      36,975 
                                                  -------        ------       ------

      Net increase (decrease) in cash and cash 
       equivalents                                 11,538        (1,215)       4,822 

      Cash and cash equivalents at beginning 
       of period                                      203         6,037            -
                                                  -------        ------       ------
      Cash and cash equivalents at end of period  $11,741        $4,822       $4,822 
                                                  -------        ------       ------
                                                  -------        ------       ------

Supplemental Disclosure of Cash Flow Information:
  Cash paid for:
    Interest                                          113             -         $280 
                                                  -------        ------       ------
                                                  -------        ------       ------

Supplemental Disclosure of Non-Cash Transaction:
  Conversion of Bridge Debentures into warrants       150             -         $150 
                                                  -------        ------       ------
                                                  -------        ------       ------
</TABLE>

            See accompanying notes to the condensed financial statements

                                      (5)
<PAGE>
                                          
                               AMERIGON INCORPORATED
                          (A DEVELOPMENT STAGE ENTERPRISE)
                      NOTES TO UNAUDITED FINANCIAL STATEMENTS


NOTE 1 -- THE COMPANY:

     Amerigon Incorporated (the "Company") is a development stage enterprise, 
which was incorporated in California on April 23, 1991 primarily to develop, 
manufacture and market proprietary, high technology automotive components and 
systems for gasoline-powered and electric vehicles.

NOTE 2 -- BASIS OF PRESENTATION AND SUMMARY OF CERTAIN ACCOUNTING POLICIES:

     The accompanying balance sheets as of March 31, 1998 and the statements 
of operations and cash flows for the three months ended March 31, 1998 and 
for the period from April 23, 1991 (inception) to March 31, 1998 have been 
prepared by the Company without audit.  In the opinion of management, all 
adjustments (consisting of normal recurring adjustments) necessary for fair 
presentation have been included. The results of operations for the three 
month period ended March 31, 1998 are not necessarily indicative of the 
operating results for the full year.

     Certain information and footnote disclosures normally included in 
financial statements prepared in accordance with generally accepted 
accounting principles have been condensed or omitted.  These condensed 
financial statements should be read in conjunction with the financial 
statements and notes thereto included in the Company's Form 10-K for the year 
ended December 31, 1997.

     DEVELOPMENT CONTRACT REVENUES AND RELATED GRANTS.  Historically, the 
Company entered into a number of fixed price contracts under which revenue is 
recognized using the percentage of completion method, or in the case of short 
duration contracts, when the prototype or services are delivered.  
Development contract revenues earned are recorded on the balance sheet as 
Unbilled Revenue until billed.  The Company has received government grants, 
which paralleled one of its development contracts.  These grants are included 
in development contract and related grant revenues.

     GRANT REVENUES.  Revenue from government agency grants and other sources 
pursuant to cost-sharing arrangements is recognized when reimbursable costs 
have been incurred.  Grant revenues earned are recorded on the balance sheet 
as Unbilled Revenue until billed.

                                      (6)

<PAGE>

NOTE 3 -- NET LOSS PER SHARE:

     The Company's net loss per share calculations are based upon the weighted
average number of shares of common stock outstanding.  Excluded from this
calculation are the 3,000,000 Escrowed Contingent Shares.  Common stock
equivalents (stock options and stock warrants) are anti-dilutive in both periods
and are excluded from the net loss per share calculation.

                                      (7)

<PAGE>

PART 1
                                          
                                       ITEM 2
                                          
                      MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                   FINANCIAL CONDITION AND RESULTS OF OPERATIONS

RESULTS OF OPERATIONS

FIRST QUARTER 1998 COMPARED WITH FIRST QUARTER 1997

     REVENUES.  Revenues for the three months ended March 31, 1998 ("First 
Quarter 1998") were $84,000 as compared with revenues of $396,000 in the 
three months ended March 31, 1997 ("First Quarter 1997"). The decrease in 
development contract and related grant revenues was due principally to the 
completion of several  development contracts and reduced revenues related to 
prototype seat contracts. The Company does not intend to pursue any 
additional significant grants or development contracts.

     The Company intends to focus its efforts on developing its core products 
and technologies (the Climate Control Seats and radar-based sensing devices), 
developing the manufacturing capability for such products and bringing them 
to market as rapidly as possible. Because of the current development focus, 
and the decision not to pursue actively any more significant grants or 
development contracts, the Company expects that revenues for the foreseeable 
future will be significantly less than in prior periods.

     DIRECT DEVELOPMENT CONTRACT AND RELATED GRANT COSTS.  No direct 
development contract and related grant costs were incurred in the First 
Quarter 1998 compared to $869,000 in the First Quarter 1997 primarily due to 
the end of activity in the Company's electric vehicle program (related to 
development contracts) and the divestiture of the IVS-TM- product line. 
Additionally, all expenses related to prototype orders from customers for 
seat and  radar products and costs associated with the electric vehicle 
program are recorded as research development expense for the First Quarter 
1998. 

     RESEARCH AND DEVELOPMENT EXPENSES.  Research and development expenses 
increased to $1,024,000 in First Quarter 1998 from $256,000 in First Quarter 
1997.  The increase in First Quarter 1998 was due to higher levels of 
research and development activity on the Company's  Climate Control Seats and 
radar products. As mentioned previously all expenses related to prototype 
orders from customers for these two products and the electric vehicle program 
are now recorded as research and development expense. As the Company begins 
to focus on the development of its core products, these expenses can be 
expected to increase in future periods.  

     SELLING, GENERAL AND ADMINISTRATIVE EXPENSES.  Selling, general and
administrative ("SG&A") expenses increased to $1,013,000 in First Quarter 1998
compared to $794,000 in First 

                                     (8)

<PAGE>

Quarter 1997. The increase in First Quarter 1998 was due to the fact that 
fewer SG&A expenses were allocated to development contracts and an increase 
in legal fees. Direct and indirect overhead expenses included in SG&A that 
are associated with development contracts were allocated to such contracts. 
As the Company has not obtained and is not actively pursuing any replacement 
development contracts, the Company anticipates that SG&A expenses will 
continue to increase in 1998 as compared to prior year comparisons. The 
Company also expects SG&A expenses to increase as it hires additional 
employees in connection with the development of radar products and the 
development and marketing of Climate Control Seats .

     INTEREST EXPENSE. Net interest income in 1998 increased due to cash 
invested related to the receipt of proceeds from the secondary offering.

LIQUIDITY AND CAPITAL RESOURCES

     At March 31, 1998, the Company had working capital of $6,696,000. The 
Company's principal sources of operating capital have been the proceeds of 
its various financing transactions and, to a lesser extent, revenues from 
grants, development contracts and sale of prototypes to customers. 

     Cash and cash equivalents decreased by $1,215,000 in 1998 primarily due 
to cash used in operating activities. Operating activities used $1,845,000, 
which was primarily a result of the net loss of $1,857,000. Investing 
activities provided $637,000, of which $370,000 was related to the purchase 
of property and equipment, offset by $1,007,000 related to the sale of 
Treasury Bills. 

     The Company expects to incur losses for the foreseeable future due to 
the continuing cost of its product development and marketing activities and 
to begin volume manufacturing operations when it is required.  To fund its 
operations, the Company will use current cash and investments, but will need 
cash from financing sources before the Company can achieve profitability from 
its operations. There can be no assurance that profitability can be achieved 
in the future. The Company is focused on bringing products to market and 
achieving revenues based upon its available resources. The Company will 
continue its program to divest assets or businesses where it does not have 
sufficient resources to bring the product to market and where it will enhance 
shareholder value. As has been previously mentioned, the Company is now 
striving to accomplish a strategic venture with the Company's electric 
vehicle program. The Company believes this divestiture will allow the Company 
to pursue the market introduction of its Climate Control Seats and 
radar-based sensor device, both for the automotive marketplace. Although the 
Company has begun limited production on its Climate Control Seat product, 
larger orders for the seat product and the ability to begin production on the 
radar product will require significant expenses for tooling product parts and 
to set up manufacturing and/or assembly processes. The Company also expects 
to require significant capital to fund other near-term production engineering 
and manufacturing, as well as research and development and marketing of these 
products. The Company does not intend to pursue any more significant grants 
or development contracts to fund operations and therefore is highly dependent 
on its current working capital sources. Should the Company not achieve 
profitability in the near future from the two above mentioned products, 

                                      (9)

<PAGE>

additional equity and/or debt financing would be required. There can be no 
assurance that either of these sources would be available in the future and 
may be required in any case.
     
     Certain matters discussed or referenced in this report, including the 
Company's intention to develop, manufacture and market Climate Control Seats 
and radar products and the Company's expectation of reduced revenues and 
continuing losses for the foreseeable future, are forward looking statements. 
Other forward looking statements may be identified by the use of forward 
looking terminology such as "may", "will", "expect", "believe", "estimate", 
"anticipate", "continue", or similar terms, variations of such terms or the 
negative of such terms. Such statements are based upon management's current 
expectations and are subject to a number of risks and uncertainties which 
could cause actual results to differ materially from those described in the 
forward looking statements. Such risks and uncertainties include the market 
demand for and performance of the Company's products, the Company's ability 
to develop, market and manufacture such products successfully, the viability 
and protection of the Company's patents and other proprietary rights, and the 
Company's ability to obtain new sources of financing. Additional risks 
associated with the company and its business and prospects are described in 
the Company's Annual Report on Form 10-K for the year ended December 31, 
1997. 

                                      (10)

<PAGE>

PART II
                                          
                                 OTHER INFORMATION


ITEM 6.   EXHIBITS AND REPORTS ON FORM 8-K.

          (a)  Exhibits
               
          None

          (b)  Reports on Form 8-K
          
          None

                                      (11)

<PAGE>

                                   SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.


                                       Amerigon Incorporated
                                       ---------------------
                                       Registrant




Date: April 30, 1998                   /s/ Scott O. Davis
                                       ------------------
                                       Scott O. Davis
                                       Vice President Finance and 
                                       Chief Financial Officer

                                      (12)

<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               MAR-31-1998
<CASH>                                           4,822
<SECURITIES>                                     1,393
<RECEIVABLES>                                    1,294
<ALLOWANCES>                                      (80)
<INVENTORY>                                        193
<CURRENT-ASSETS>                                 7,670
<PP&E>                                           2,089
<DEPRECIATION>                                 (1,178)
<TOTAL-ASSETS>                                   8,581
<CURRENT-LIABILITIES>                              974
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        28,149
<OTHER-SE>                                    (20,576)
<TOTAL-LIABILITY-AND-EQUITY>                     8,581
<SALES>                                              0
<TOTAL-REVENUES>                                    84
<CGS>                                                0
<TOTAL-COSTS>                                    2,037
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (1,857)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (1,857)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,857)
<EPS-PRIMARY>                                   (0.19)
<EPS-DILUTED>                                   (0.19)
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission